ELYM
Eliem Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website eliemtx.com
- Employees(FY) 30
- ISIN US28658R1068
Performance
-7.82%
1W
+80.92%
1M
+215.9%
3M
+236.73%
6M
+205.56%
YTD
+191.52%
1Y
Profile
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial. The company was incorporated in 2018 and is headquartered in Redmond, Washington.
Technical Analysis of ELYM 2024-05-10
Overview:
In analyzing the technical indicators for ELYM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been consistently above the closing prices, in...
Recent News & Updates
- 2024-05-15 01:53
- 2024-04-11 02:42
- 2024-04-10 19:00
- 2024-04-04 18:53
- 2023-07-20 19:17
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%(Yahoo Finance)
- 2023-07-19 18:45
- 2023-05-11 04:10
- 2023-04-21 00:00
- 2023-04-20 22:39
Top 10 Stocks Activist Investors Are Targeting(Yahoo Finance)
- 2023-03-06 03:10
- 2023-02-22 11:38
Eliem Therapeutics slashing staff amid leadership shakeup(Yahoo Finance)
- 2023-02-09 20:31
- 2023-02-09 03:01
- 2022-11-29 18:00
- 2022-11-13 17:10
- 2022-11-11 19:47
- 2022-11-07 18:00
- 2022-10-04 23:20
- 2022-10-04 19:00
Eliem Therapeutics Provides Update on Pipeline Progress(Yahoo Finance)
- 2022-08-14 18:10
- 2022-08-01 21:33
- 2022-08-01 19:58
- 2022-08-01 19:00
Eliem Therapeutics Provides ETX-810 Program Update(Yahoo Finance)
- 2022-07-17 21:20
- 2022-07-17 19:00
- 2022-07-06 19:00
- 2022-06-27 04:01
- 2022-05-15 18:10
- 2022-05-09 22:45
Reata (RETA) Q1 Earnings Top, Omaveloxolone MAA Likely in Q4(Yahoo Finance)
- 2022-05-08 21:55
Page 1 of 2
previousnext